Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RP11-832A4.7 (ENSG00000280032) is a long non-coding RNA gene with regulatory roles in gene expression. It can act as an enhancer, recruit transcription factors, and interact with splicing factors, impacting the regulation of neighboring or target protein-coding genes. Differential expression of this lncRNA has been observed between tumor and normal tissues, with possible involvement in cancer biology, particularly prostate and lung cancers. However, there are no established direct therapeutic interventions targeting this lncRNA, nor is it classified as a canonical druggable target.
Not applicable; no drug mechanisms described for this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RP11-832A4.7 (None established; sometimes abbreviated as RP11-832A4.7).